HUM-MOLGEN events: Marrow Transplantation in Children: Current Results and Controversies

HUM-MOLGEN -> Events -> Meetings and Conferences

Marrow Transplantation in Children: Current Results and Controversies - Meeting #6

April 18, 2001

The Alfred I duPont Hospital for Children of The Nemours Foundation, World Golf Village Renaissance Resort
November 8-10, 2001

AGENDA
Thursday, November 8, 2001

Introduction, Welcome and Instructions: Michael E. Trigg, M.D.

SESSION I

A. Stem Cell Sources – Frank Smith, M.D., Chair

Jeffrey M. Lipton, M.D., Ph.D., “Peripheral Blood as a Stem Cell Source in Children: Is the Effort in Vein?”

Chatchada Karanes, M.D., “The Impact of Selection of Unrelated Donors on Outcome of Allogeneic Stem
Cell Transplant”

Rupert Handgretinger, M.D., Ph.D., “Megadose Transplantation of Highly Purified Haploidentical Stem Cells: Current Results and Future Prospects”

John E. Wagner, Jr., M.D., “Umbilical Cord Blood Versus Marrow Stem Cells: That is the Question”

B. Preparative Regimens – Jean Sanders, M.D., Chair

Dana Matthews, M.D., “Radiolabeled Antibodies in Children: Can We Use Them? Should We?”

Thomas R. Spitzer, M.D., “The Expanding Applications of Non-Myeloablative Stem Cell Transplantation”

Bruce Bostrom, M.D., “Busulfan: Formulations and Pharmacokinetics”

SESSION II

C. High dose ablative or non-ablative therapy with stem cell rescue - - to transplant or not to transplant? – James Nachman, M.D., Chair

Martin Schrappe, M.D., Ph.D., “Identification and Treatment of High-Risk ALL With and Without Stem Cell Transplantation”

James Nachman, M.D., “Population Based Study of Impact of Allogeneic BMT on Outcome for Children With ALL in Second Remission”

Howard J. Weinstein, M.D., “AML – The Road to Remission and Marrow Transplant Controversies”

D. Graft vs. Host Disease – Eric Sandler, M.D., Chair

Eva C. Guinan, M.D., “Transplant and Tolerance”

Paul A. Carpenter, M.D., “Steroid Refractory GvHD: Past, Present and Future”

Reception and poster session (in room with posters)

Friday, November 9, 2001

SESSION III

E. Infectious Disease and Supportive Care Issues – Michael E. Trigg, M.D., Chair

John R. Wingard, M.D., “Advances in Antifungal Therapies”

Susan F. Leitman, M.D., “”The Role of Granulocyte Transfusions Following Stem Cell Transplantation””

Stephen Chanock, M.D., “The Human Genome and Transplantation Outcomes: Challenges and Future Considerations”

Thomas G. Gross, M.D., Ph.D., “EBV PTLD – Can it be Prevented or Cured?”

Madelyn Kahana, M.D., “Novel ICU Care for Pediatric Bone Marrow Transplant Recipients”

Deborah C. Molrine, M.D., “Recommendations for Immunizations in Stem Cell Transplantation”

Ronald Barr, M.D., “Costs and Consequences of Stem Cell Transplants in Children”

F. Choice of a Transplant Center: Parent Panel – Eric Sandler, M.D., Chair

Nursing Symposium

Saturday, November 10, 2001

SESSION IV

G. Clinical Research – Frank Smith, M.D., Chair

Charles Peterson, MD, MBA, “Blood and Marrow Transplant Clinical Research network"

Norman C. Fost, M.D., MPH, “Conception for Donation: What’s Wrong with Engineering Donors?”

Phyllis I. Warkentin, M.D., “Hematopoietic Stem Cell Transplants: Regulation and Accreditation”

H. Chairman’s symposium – Michael E. Trigg, M.D., Chair

Edwin Horwitz, M.D., Ph.D., “Bone Marrow Transplantation: It’s Not Just About Blood Anymore”

Leonard Mattano, M.D., “The Skeletal Remains: Porosis & Necrosis of Bone in the Marrow Transplantation Setting”

Donald Orlic, Ph.D., “Bone Marrow Stem Cells Regenerate Infarcted Myocardium”

Adjourn

Organized by:

Michael E. Trigg, M.D.

Invited Speakers:

Ronald Barr, MD (McMaster University, Hamilton, Ontario, Canada)
Bruce Bostrom, MD (Minneapolis Children’s Medical Center, Minneapolis, MN)
Paul A. Carpenter, MD (University of Washington, Seattle, WA)
Stephen Chanock, MD (National Cancer Institute in Bethesda, MD)
Norman C. Fost, MD, MPH (University of Wisconsin, Madison, WI)
Thomas C. Gross, MD, PhD (Children’s Hospital Medical Center, Cincinnati, OH)
Eva C. Guinan, MD (Dana-Farber Cancer Institute and Children’s Hospital, Boston, MA)
Rupert Handgretinger, MD, PhD (St. Jude Children’s Research Center, Memphis, TN)
Edwin M. Horwitz, MD, PhD (St. Jude Children’s Research Hospital, Memphis, TN)
Madelyn Kahana, MD (Associate Professor, Clinical Anesthesia, Chicago, IL)
Chatchada Karanes, MD (National Marrow Donor Program, Minneapolis, MN)
Susan F. Lietman, MD (National Institutes of Health, Bethesda, MD)
Jeffrey M. Lipton, MD, PhD (Schneider Children’s Hospital, New Hyde Park, NY)
Leonard A. Mattano, Jr., MD (Kalamazoo CCOP, Kalamazoo, MI)
Dana C. Matthews, MD (Fred Hutchinson Cancer Research Center, Seattle, WA)
Deborah C. Molrine, MD (Boston Children’s Hospital, Boston, MA)
James Nachman, MD (University of Chicago, Chicago, IL)
Donald Orlic, PhD (National Human Genome Research Institute, Bethesda, MD)
Charles M. Peterson, MD, MBA (National Institutes of Health, Bethesda, MD)
Martin Schrappe, MD, PhD (Medizinische Hochschule Hannover, Germany)
Thomas R. Spitzer, MD (Massachusetts General Hospital, Boston, MA 02114-2606)
John E. Wagner, Jr., MD (University of Minnesota Hospital & Clinics, Minneapolis, MN)
Phyllis I. Warkentin, MD (University of Nebraska Medical Center, Omaha, NE)
Howard J. Weinstein, MD (Massachusetts General Hospital, Boston, MA)
John R. Wingard, MD (University of Florida College of Medicine, Gainesville, L)

Deadline for Abstracts:

August 1, 2001

Registration:

$450 - physicians prior to August 1, 2001
$500 - physicians after August 2, 2001
$250 - Nurses and physician assistants

E-mail:

kbidus@nemours.org

Posted by:

Jeanne M. Danboise

Host:

aidiw3.nemours.org